LUPUS ERYTHEMATOSUS, SYSTEMIC
Clinical trials for LUPUS ERYTHEMATOSUS, SYSTEMIC explained in plain language.
Never miss a new study
Get alerted when new LUPUS ERYTHEMATOSUS, SYSTEMIC trials appear
Sign up with your email to follow new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive 1,620-Patient study tracks new lupus Drug's Real-World performance
Disease control OngoingThis study is collecting real-world information on the long-term safety and effectiveness of Saphnelo (anifrolumab) for people with systemic lupus erythematosus. It involves 1,620 patients who haven't responded well to current treatments. The goal is to monitor how the drug perfo…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
3-Year lupus drug safety check underway
Disease control ENROLLING_BY_INVITATIONThis study aims to learn about the long-term safety and side effects of the drug cenerimod for adults with moderate-to-severe lupus. It will follow about 680 people who took part in earlier trials, giving them cenerimod along with their standard lupus medications for up to 3 year…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Major trial aims to tame the flames of lupus
Disease control OngoingThis study is testing an investigational drug called litifilimab for adults with active systemic lupus erythematosus (SLE). The goal is to see if adding monthly injections of litifilimab to a patient's standard lupus medications can better control the disease, reduce symptom flar…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Major trial tests new pill to tame severe lupus flares
Disease control OngoingThis study is testing if a new oral drug called cenerimod helps control symptoms when added to standard treatments for adults with moderate-to-severe lupus. About 420 participants will take either cenerimod or a placebo pill daily for one year, while continuing their usual lupus …
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Major trial aims to tame the flames of lupus
Disease control OngoingThis large, late-stage study is testing whether a new injectable drug called litifilimab can better control active systemic lupus. About 550 adults who are already on standard lupus medications will receive either the drug or a placebo for a year. The main goal is to see if litif…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
Brain fog breakthrough? common drug tested for Lupus-Related memory loss
Symptom relief OngoingThis study is testing whether a drug called memantine can safely help with the memory and thinking problems (often called 'brain fog') that many people with lupus experience. For 14 weeks, 111 participants with lupus and measured cognitive impairment will receive either memantine…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
Gentle exercise trial offers new hope for lupus fatigue and pain
Symptom relief ENROLLING_BY_INVITATIONThis study is testing whether a specific exercise program, called clinical Pilates, can help women with lupus feel better. It aims to see if these exercises can reduce common problems like severe tiredness, pain, poor sleep, and low mood. The study will compare a home exercise pr…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: Emir İbrahim IŞIK • Aim: Symptom relief
Last updated Mar 20, 2026 14:47 UTC
-
Can a phone app help teens with lupus fight depression and stay on track with care?
Symptom relief ENROLLING_BY_INVITATIONThis study aims to understand if depression makes it harder for teens and young adults with lupus to keep up with their medical care. Researchers are testing a specially designed mobile app to see if it's a helpful and practical tool for improving both mood and care engagement. T…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Mar 02, 2026 15:26 UTC
-
Scientists search for clues in blood and bone marrow to unlock autoimmune disease mysteries
Knowledge-focused ENROLLING_BY_INVITATIONThis research study aims to understand how autoimmune diseases like lupus develop by comparing immune cells from people with autoimmune conditions, people with infectious diseases, and healthy individuals. Researchers will collect blood and sometimes bone marrow samples from 2,50…
Matched conditions: LUPUS ERYTHEMATOSUS, SYSTEMIC
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC